{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:32:55Z","timestamp":1771903975255,"version":"3.50.1"},"reference-count":71,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/17425255.2018.1488964","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T16:16:18Z","timestamp":1528906578000},"page":"753-760","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome"],"prefix":"10.1080","volume":"14","author":[{"given":"Eugenia","family":"Bruzzese","sequence":"first","affiliation":[{"name":"Department of Translational Medical Science, \u2018Federico II\u2019 University of Naples 80131, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, \u2018Federico II\u2019 University of Naples 80131, Naples, Italy"},{"name":"Division of Neurogastroenterology &amp; Motility, Department of Pediatric Gastroenterology, Great Ormond Street, Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Sarnelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, \u2018Federico II\u2019 University of Naples 80131, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guarino","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, \u2018Federico II\u2019 University of Naples 80131, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12728"},{"key":"CIT0004","first-page":"G775","volume":"303","author":"Camilleri M","year":"2012","journal-title":"The Confluence of Increased Permeability, Inflammation, and Pain in Irritable Bowel Syndrome. Am J Physiol Gastrointest Liver Physiol."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7010006"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3748\/wjg.v20.i2.384","volume":"20","author":"El-Salhy M","journal-title":"World J Gastroenterol. 2014"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.200"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.5.746"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.055"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12250"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.4"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0323-7"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.01.142"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9839-8"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1517\/17425250902973695"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-8-200610170-00004"},{"key":"CIT0020","first-page":"960","volume":"28","author":"Marchi E","year":"1985","journal-title":"A New Series of Semisynthetic Rifamycins with High Antibacterial Activity and Low Gastroenteric Absorption. J Med Chem."},{"key":"CIT0021","first-page":"467","volume":"49","author":"Gillis JC","year":"1995","journal-title":"Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2174\/1389557515666150722110201"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8390595"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.32"},{"key":"CIT0025","first-page":"309","volume":"8","year":"2015","journal-title":"Soldi S, Vasileiadis S, Uggeri F, et al. Modulation of the gut microbiota composition by Rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach. Clin Exp Gastroenterol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.01.007"},{"key":"CIT0027","first-page":"639","volume":"49","author":"Esposito G","journal-title":"Int J Oncol. 2016;"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.234096"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00120"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.170225"},{"key":"CIT0031","author":"Cianci R","year":"2014","journal-title":"J Immunol Res. 2014;"},{"key":"CIT0032","first-page":"239","volume":"24","author":"Cianci R","year":"2010","journal-title":"J Biol Reg Homeost Ag."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00458.x"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004409"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.026"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.355"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.003"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1889-2"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1728-5"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00431-004-1437-6","volume":"163","author":"El-Matary W","year":"2004","journal-title":"Eur J Pediatr"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.015"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13696"},{"key":"CIT0043","first-page":"627","volume":"107","author":"Vlieger AM","journal-title":"Standard Care in Children with Functional Abdominal Pain or Irritable Bowel Syndrome. Am J Gastroenterol. 2012"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000304454.99799.42"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1026-7"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.03.033"},{"key":"CIT0047","first-page":"S488","volume":"104","author":"Infantalino ADJ","year":"2009","journal-title":"J Gastroenterol"},{"key":"CIT0048","first-page":"1314","volume":"17","author":"Scarpellini E","year":"2013","journal-title":"Rev Med Pharmacol Sci"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0026-895X(25)11449-1","volume":"27","author":"Cellai L","year":"1985","journal-title":"Mol Pharmacol"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1159\/000081990"},{"key":"CIT0051","volume-title":"Rifaximin (Revised Monograph) Suppl. 2011; 7.1:2362","author":"European Pharmacopoeia"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1039\/b717887e"},{"key":"CIT0053","first-page":"1","volume-title":"Polymorphismin pharmaceutical solids","author":"Grant DJW","year":"1999"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.005"},{"issue":"1079","key":"CIT0055","first-page":"70","volume":"2011","author":"Viscomi GC","journal-title":"WHO"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.05.001"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1159\/000238165"},{"key":"CIT0058","first-page":"373","volume":"3","author":"Cellai L","journal-title":"Chemioterapia. 1984"},{"key":"CIT0059","first-page":"51","volume":"14","author":"Descombe JJ","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"CIT0060","unstructured":"XIFAXAN\u00ae (rifaximin) Tablets, 550 mg NDA 21-361 Briefing Document for Gastrointestinal Drugs Advisory Committee Meeting and XIFAXAN\u00aePackage Insert."},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01108-07"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050426"},{"key":"CIT0063","first-page":"31","volume":"5","author":"Koo HL","journal-title":"Clin Med Insights Gastroenterol. 2012;"},{"key":"CIT0065","first-page":"e25","volume":"45","author":"Hoffman JT","year":"2011","journal-title":"Pharmacother"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H395"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.10.1361"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12735"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trt059"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140050-00002"},{"issue":"362","key":"CIT0073","first-page":":887","author":"Frieden TR, Sterling TR, Munsiff SS, et al","journal-title":"Lancet. 2003;"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199809000-00013"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.713"},{"key":"CIT0076","first-page":"33","volume":"14","author":"Fietta A","journal-title":"J Chemother. 2002;"},{"key":"CIT0077","first-page":"281","volume":"26","author":"Cresti S","year":"2003","journal-title":"New Microbiol."},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11398734"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1488964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:24:39Z","timestamp":1751685879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1488964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,7]]},"published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/17425255.2018.1488964"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1488964","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}